By applying this concept along with a drug-repurposing approach, we here report that administration of (R)-DI-87, a soluble, orally active, and high-affinity inhibitor of host dCK (Poddar et al., 2020), reduces S. aureus abscess formation in a mouse model of bloodstream infection. Here, DCK is linked to abscess.